Peptide synthesis is characterized as the formation of a peptide bond between two amino acids. Peptide synthesis most often occurs by coupling the carboxyl group of the incoming amino acid to the N-terminus of the growing peptide chain. Peptide synthesis is a common approach in even high-throughput biological research and product and drug development.
Market Dynamics
Rising incidence of metabolic disorders such as diabetes is expected to drive the peptide synthesis market growth. For instance, according to an article published by the journal Diabetes Research and Clinical Practice - 'Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition in September 2019, 463 million people were estimated to suffer from diabetes in 2019 worldwide and the number is expected to reach 578 million by 2030 and 700 million by 2045.
However, sustainability in synthetic peptide production is expected to hinder the market growth. For instance, according to an article published by the ProteoGenix in November 2019, reports that development of sustainable and efficient catalytic methods is the major challenge in peptide synthesis.
Key features of the study:
- This report provides in-depth analysis of the global peptide synthesis market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global peptide synthesis market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include GenScript Biotech Corporation, Merck KGaA, ThermoFisher Scientific Inc., Syngene, Lonza, Novo Nordisk A/S, Bachem Holding AG, Gyros Protein Technologies, Creative Diagnostics, CEM Corporation, PuroSynth, AAPPTec, and Biotage AB among others
- Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
- The global peptide synthesis market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global peptide synthesis market.
Detailed Segmentation:
- Global Peptide Synthesis Market, By Product:
- Reagents & Consumables
- Equipment
- Peptide Synthesizers
- Lyophilizers
- Chromatography Equipment
- Global Peptide Synthesis Market, By Technology:
- Solid Phase
- Liquid Phase
- Hybrid & Recombinant
- Global Peptide Synthesis Market, By Application:
- Therapeutics
- Metabolic Disorders
- Cardiovascular Disorders
- Respiratory Disorders
- Infectious Diseases
- Others
- Diagnosis
- Research
- Global Peptide Synthesis Market, By End User:
- Pharmaceutical and Biotechnology Companies
- Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
- Academic and Research Institutes
- Global Peptide Synthesis Market, By Region:
- North America
- By Product:
- Reagents & Consumables
- Equipment
- Peptide Synthesizers
- Lyophilizers
- Chromatography Equipment
- By Technology:
- Solid Phase
- Liquid Phase
- Hybrid & Recombinant
- By Application:
- Therapeutics
- Metabolic Disorders
- Cardiovascular Disorders
- Respiratory Disorders
- Infectious Diseases
- Others
- Diagnosis
- Research
- By End User:
- Pharmaceutical and Biotechnology Companies
- Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
- Academic and Research Institutes
- By Country:
- Latin America
- By Product:
- Reagents & Consumables
- Equipment
- Peptide Synthesizers
- Lyophilizers
- Chromatography Equipment
- By Technology:
- Solid Phase
- Liquid Phase
- Hybrid & Recombinant
- By Application:
- Therapeutics
- Metabolic Disorders
- Cardiovascular Disorders
- Respiratory Disorders
- Infectious Diseases
- Others
- Diagnosis
- Research
- By End User:
- Pharmaceutical and Biotechnology Companies
- Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
- Academic and Research Institutes
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Product:
- Reagents & Consumables
- Equipment
- Peptide Synthesizers
- Lyophilizers
- Chromatography Equipment
- By Technology:
- Solid Phase
- Liquid Phase
- Hybrid & Recombinant
- By Application:
- Therapeutics
- Metabolic Disorders
- Cardiovascular Disorders
- Respiratory Disorders
- Infectious Diseases
- Others
- Diagnosis
- Research
- By End User:
- Pharmaceutical and Biotechnology Companies
- Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
- Academic and Research Institutes
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Product:
- Reagents & Consumables
- Equipment
- Peptide Synthesizers
- Lyophilizers
- Chromatography Equipment
- By Technology:
- Solid Phase
- Liquid Phase
- Hybrid & Recombinant
- By Application:
- Therapeutics
- Metabolic Disorders
- Cardiovascular Disorders
- Respiratory Disorders
- Infectious Diseases
- Others
- Diagnosis
- Research
- By End User:
- Pharmaceutical and Biotechnology Companies
- Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
- Academic and Research Institutes
- By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Product:
- Reagents & Consumables
- Equipment
- Peptide Synthesizers
- Lyophilizers
- Chromatography Equipment
- By Technology:
- Solid Phase
- Liquid Phase
- Hybrid & Recombinant
- By Application:
- Therapeutics
- Metabolic Disorders
- Cardiovascular Disorders
- Respiratory Disorders
- Infectious Diseases
- Others
- Diagnosis
- Research
- By End User:
- Pharmaceutical and Biotechnology Companies
- Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
- Academic and Research Institutes
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Product:
- Reagents & Consumables
- Equipment
- Peptide Synthesizers
- Lyophilizers
- Chromatography Equipment
- By Technology:
- Solid Phase
- Liquid Phase
- Hybrid & Recombinant
- By Application:
- Therapeutics
- Metabolic Disorders
- Cardiovascular Disorders
- Respiratory Disorders
- Infectious Diseases
- Others
- Diagnosis
- Research
- By End User:
- Pharmaceutical and Biotechnology Companies
- Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
- Academic and Research Institutes
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- Company Profiles
- GenScript Biotech Corporation.*
- Company Overview
- Product Portfolio
- Financial Performance
- Key Highlights
- Market Strategies
- Merck KGaA
- ThermoFisher Scientific Inc.
- Syngene
- Lonza
- Novo Nordisk A/S
- Bachem Holding AG
- Gyros Protein Technologies
- Creative Diagnostics
- CEM Corporation
- PuroSynth
- AAPPTec
- Biotage AB
“*” marked represents similar segmentation in other categories in the respective section.
